Cargando…
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311064/ https://www.ncbi.nlm.nih.gov/pubmed/34309715 http://dx.doi.org/10.1007/s00277-021-04584-y |
_version_ | 1783728887032709120 |
---|---|
author | Ruhe, Johannes Schnetzke, Ulf Kentouche, Karim Prims, Florian Baier, Michael Herfurth, Konstantin Schlosser, Mandy Busch, Martin Hochhaus, Andreas Wolf, Gunter |
author_facet | Ruhe, Johannes Schnetzke, Ulf Kentouche, Karim Prims, Florian Baier, Michael Herfurth, Konstantin Schlosser, Mandy Busch, Martin Hochhaus, Andreas Wolf, Gunter |
author_sort | Ruhe, Johannes |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8311064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83110642021-07-26 Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Ruhe, Johannes Schnetzke, Ulf Kentouche, Karim Prims, Florian Baier, Michael Herfurth, Konstantin Schlosser, Mandy Busch, Martin Hochhaus, Andreas Wolf, Gunter Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2021-07-26 2022 /pmc/articles/PMC8311064/ /pubmed/34309715 http://dx.doi.org/10.1007/s00277-021-04584-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Ruhe, Johannes Schnetzke, Ulf Kentouche, Karim Prims, Florian Baier, Michael Herfurth, Konstantin Schlosser, Mandy Busch, Martin Hochhaus, Andreas Wolf, Gunter Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title | Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title_full | Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title_fullStr | Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title_full_unstemmed | Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title_short | Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
title_sort | acquired thrombotic thrombocytopenic purpura after first vaccination dose of bnt162b2 mrna covid-19 vaccine |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311064/ https://www.ncbi.nlm.nih.gov/pubmed/34309715 http://dx.doi.org/10.1007/s00277-021-04584-y |
work_keys_str_mv | AT ruhejohannes acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT schnetzkeulf acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT kentouchekarim acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT primsflorian acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT baiermichael acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT herfurthkonstantin acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT schlossermandy acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT buschmartin acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT hochhausandreas acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine AT wolfgunter acquiredthromboticthrombocytopenicpurpuraafterfirstvaccinationdoseofbnt162b2mrnacovid19vaccine |